<bill session="115" type="s" number="2535" updated="2019-04-18T16:42:06Z">
  <state datetime="2018-05-24">REPORTED</state>
  <status>
    <unknown datetime="2018-05-24"/>
  </status>
  <introduced datetime="2018-03-12"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to strengthen Drug Enforcement Administration discretion in setting opioid quotas.</title>
    <title type="short" as="reported to senate">Opioid Quota Reform Act</title>
    <title type="short" as="reported to senate">Opioid Quota Reform Act</title>
    <title type="short" as="introduced">Opioid Quota Reform Act</title>
    <title type="short" as="introduced">Opioid Quota Reform Act</title>
    <title type="display">Opioid Quota Reform Act</title>
  </titles>
  <sponsor bioguide_id="D000563"/>
  <cosponsors>
    <cosponsor bioguide_id="F000062" joined="2018-03-12"/>
    <cosponsor bioguide_id="G000386" joined="2018-03-12"/>
    <cosponsor bioguide_id="K000393" joined="2018-03-12"/>
    <cosponsor bioguide_id="M001183" joined="2018-09-06"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-12">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-03-12" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <reference ref="CR S1632" label="text of measure as introduced"/>
    </action>
    <calendar datetime="2018-05-24" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </calendar>
    <action datetime="2018-06-19">
      <text>Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2018-06-19" calendar="Senate Legislative" under="General Orders" number="473">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 473.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Congressional oversight"/>
    <term name="Department of Justice"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health information and medical records"/>
  </subjects>
  <amendments/>
  <summary date="2018-03-12T04:00:00Z" status="Introduced in Senate">Opioid Quota Reform Act

This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to consider additional factors&#8212;the impact on overall public health and rates of diversion, abuse, and overdose deaths&#8212;in setting and adjusting production and manufacturing quotas for fentanyl, oxycodone, hydrocodone, oxymorphone, and hydromorphone.

Additionally, if the DEA increases the production quota of fentanyl, oxycodone, hydrocodone, oxymorphone, or hydromorphone, then it must explain why the public health benefits of increasing the quota outweigh the consequences of potential diversion.</summary>
  <committee-reports/>
</bill>
